When describing the why behind the newly launched company, Petra Willems – who has been appointed managing director of Organon Benelux – speaks with ambition and shares a clear vision: “It’s a unique opportunity to build a new company that seeks to be a leader in women’s health. There’s an urgent need to look at syndromes and conditions that only affect women or that affect them disproportionately compared to men. Providing a healthier future for women also entails a healthier future for their families and communities around the globe.”
Willems’ words also make it blatantly clear: while Organon boasts a long legacy, its focus is relevant to contemporary challenges. The company’s roots date back to as early as 1923 when it was founded by Dr. Saal van Zwanenberg in the Dutch town of Oss. While still treasuring its roots, the new Organon is different: no other major pharmaceutical company focuses primarily on women’s health to such an extent.